Loading organizations...
Alden develops an integrated platform for rapid, accurate diagnostic information and microbe testing in agriculture. Its proprietary SSSA biosensor technology provides dependable pathogen detection, often within hours. The system offers both on-site point-of-care and off-site laboratory services, ensuring operational efficiency and product safety by eliminating live pathogens from the testing process.
Founded in 2018 by Elijah Sharpe, Alden addressed inefficiencies in existing microbe testing methods. Sharpe recognized traditional diagnostics, like PCR, were slow and complex, impeding crucial decisions. This insight led to Alden’s advanced platform, designed for superior speed, ease, and precision in pathogen detection, significantly enhancing agricultural safety.
Alden’s platform assists agricultural businesses, including food producers, in optimizing quality and safety protocols. The company’s mission is to improve global food, agricultural, and environmental safety by making advanced diagnostic information accessible and actionable. Alden envisions a safer world through its innovative, integrated testing solutions.
Alden has 2 tracked investments across 2 companies. The latest tracked deal is $5.0M Series A in Xeneta in February 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2015 | Xeneta | $5.0M Series A | — | Balderton Capital, Creandum, HV Capital, Octopus Ventures, Alliance Venture, Point Nine Capital |
| Dec 20, 2012 | bMobilized | $2.5M Series A | — | Alliance Venture, Investinor |